Abstract
A 75‐year‐old male taking ibrutinib for 5 months for relapsed mantle cell lymphoma (MCL) presented with rising lymphocyte count, headache, peri‐orbital numbness, and a rapidly progressive rash.
Original language | English |
---|---|
Pages (from-to) | 422-423 |
Number of pages | 2 |
Journal | eJHaem |
Volume | 1 |
Issue number | 2 |
Early online date | 10 Sept 2020 |
DOIs | |
Publication status | Published - Nov 2020 |